Table 2.
Prognostic value of LGD, abnormal DNA ploidy, p53 immunopositivity and inflammatory activity for neoplastic progression in high-risk IBD patients according to Cox regression analysis with time-dependent covariates
Variable | Adjusted for age | Adjusted for age and LGD | Adjusted for all other variables | |||
---|---|---|---|---|---|---|
HR (95%CI) | p | HR (95%CI) | p | HR (95%CI) | p | |
LGD | 5.5 (2.6–11.5) | <0.0001 | 2.0 (0.8–4.9) | 0.2 | ||
DNA ploidy, 1.06≤DI≤1.34a | 4.7 (2.9–7.8) | <0.0001 | 3.6 (2.2–5.9) | <0.0001 | 4.3 (2.5–7.2) | <0.0001 |
DNA ploidy, DI >1.34 | 6.6 (3.7–11.7) | <0.0001 | 5.3 (3.3–8.3) | <0.0001 | 4.8 (2.3–9.6) | <0.0001 |
p53 immunopositivityb | 3.0 (1.9–4.7) | <0.0001 | 2.2 (1.3–3.7) | 0.002 | 1.7 (1.0–3.1) | 0.04 |
Mildly active inflammation | 2.3 (0.9–5.3) | 0.07 | 2.1 (0.8–5.4) | 0.1 | 1.9 (0.7–4.9) | 0.2 |
Moderately active inflammation | 4.1 (1.8–9.1) | 0.001 | 4.0 (1.7–9.6) | 0.002 | 3.0 (1.2–7.2) | 0.02 |
Severely active inflammation | 3.4 (1.4–8.2) | 0.005 | 4.7 (2.2–9.9) | <0.0001 | 2.3 (0.9–5.9) | 0.1 |
aDI, DNA index, calculated as ratio of the abnormal G0/G1 mean peak channel number to the normal diploid G0/G1 mean peak channel number
bp53 immunopositivity, defined as moderate and intense brown staining in >15% of the nuclei [14]
LGD, low grade dysplasia